Your browser doesn't support javascript.
loading
The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients.
Bruzzese, Vincenzo; Lazzarino, Antonio Ivan.
Affiliation
  • Bruzzese V; Department of Rheumatology, Hospital Santo Spirito - Nuovo Regina Margherita, Via Emilio Morosini 30, Rome 00153, Italy.
  • Lazzarino AI; Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London WC1E 7HB, United Kingdom; Epistata - Agency for Clinical Research and Medical Statistics, 23 Kirkland Walk, London E8 3SY, United Kingdom. Electronic address: a.lazzarino@ucl.ac.uk.
Med Hypotheses ; 144: 110284, 2020 Nov.
Article in En | MEDLINE | ID: mdl-33245278
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Pulmonary Disease, Chronic Obstructive / Antibodies, Monoclonal, Humanized / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Med Hypotheses Year: 2020 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Pulmonary Disease, Chronic Obstructive / Antibodies, Monoclonal, Humanized / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Med Hypotheses Year: 2020 Document type: Article Affiliation country: Italia